M.E. Allison & CO. Inc. Takes $449,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

M.E. Allison & CO. Inc. purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 860 shares of the medical equipment provider's stock, valued at approximately $449,000.

Several other large investors have also recently added to or reduced their stakes in ISRG. Godsey & Gibb Inc. grew its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. purchased a new stake in shares of Intuitive Surgical during the third quarter worth about $33,000. Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical in the fourth quarter worth about $36,000. Capital Performance Advisors LLP purchased a new position in Intuitive Surgical in the third quarter valued at about $38,000. Finally, DT Investment Partners LLC grew its stake in Intuitive Surgical by 80.0% during the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider's stock valued at $40,000 after purchasing an additional 36 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, SVP Mark Brosius sold 2,128 shares of the company's stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,095,920.00. Following the transaction, the senior vice president now owns 273 shares in the company, valued at $140,595. This represents a 88.63 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Robert Desantis sold 188 shares of the business's stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,788,899.12. The trade was a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 48,190 shares of company stock worth $25,012,927 in the last three months. 0.80% of the stock is currently owned by insiders.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded up $8.56 during trading hours on Monday, hitting $592.64. 2,630,118 shares of the company's stock traded hands, compared to its average volume of 1,158,623. The company's fifty day simple moving average is $540.66 and its two-hundred day simple moving average is $499.64. Intuitive Surgical, Inc. has a 52 week low of $362.14 and a 52 week high of $597.68. The company has a market cap of $211.09 billion, a price-to-earnings ratio of 95.28, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. On average, analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. Morgan Stanley upgraded shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and lifted their price target for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Royal Bank of Canada upped their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the company an "outperform" rating in a research note on Friday, October 18th. Evercore ISI reiterated a "cautious" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Wells Fargo & Company raised their price objective on Intuitive Surgical from $549.00 to $630.00 and gave the stock an "overweight" rating in a research note on Wednesday, December 11th. Finally, Piper Sandler reissued an "overweight" rating and set a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company's stock. According to MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and a consensus price target of $554.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.